Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients

Journal of Chromatography. B, Biomedical Applications
C B Eap, P Baumann

Abstract

Five selective serotonin reuptake inhibitors (SSRIs) have been introduced recently: citalopram, fluoxetine, fluvoxamine, paroxetine and sertraline. Although no therapeutic window has been defined for SSRIs, in contrast to tricyclic antidepressants, analytical methods for therapeutic drug monitoring of SSRIs are useful in several instances. SSRIs differ widely in their chemical structure and in their metabolism. The fact that some of them have N-demethylated metabolites, which are also SSRIs, requires that methods be available which allow therapeutic drug monitoring of the parent compounds and of these active metabolites. most procedures are based on prepurification of the SSRIs by liquid-liquid extraction before they are submitted to separation by chromatographic procedures (high-performance liquid chromatography, gas chromatography, thin layer chromatography) and detection by various detectors (UV, fluorescence, electrochemical detector, nitrogen-phosphorus detector, mass spectrometry). This literature review shows that most methods allow quantitative determination of SSRIs in plasma, in the lower ng/ml range, and that they are, therefore, suitable for therapeutic drug monitoring purposes of this category of drugs.

References

Nov 1, 1978·European Journal of Pharmacology·E N PetersenL Wetterberg
Nov 9, 1978·European Journal of Clinical Pharmacology·K F Overø
Oct 1, 1992·Archives of General Psychiatry·D J KupferV J Grochocinski
Jan 1, 1992·Psychopharmacology·J Angst
Jan 19, 1990·Journal of Chromatography·S H WongH Kranzler
Jul 1, 1989·Biomedical Chromatography : BMC·J Pommery, M Lhermitte
Jan 1, 1989·Therapeutic Drug Monitoring·M W KellyM J Garvey
Mar 1, 1995·International Clinical Psychopharmacology·P Baumann, B Rochat
Oct 1, 1994·Clinical Pharmacokinetics·P J Goodnick
Nov 1, 1994·Biomedical Chromatography : BMC·S H WongR Fernandes
Nov 18, 1994·Journal of Chromatography. B, Biomedical Applications·R N Gupta
Sep 1, 1994·Clinical Pharmacokinetics·E PeruccaE Spina
Mar 1, 1994·International Clinical Psychopharmacology·J Hyttel
Dec 1, 1993·The Clinical Investigator·K Brøsen
Mar 1, 1994·Clinical Pharmacokinetics·A C AltamuraM Percudani
Mar 1, 1993·Clinical Pharmacokinetics·J van Harten
Jan 1, 1993·International Clinical Psychopharmacology·T R NormanF K Judd
Nov 1, 1995·Journal of Pharmacological and Toxicological Methods·D B GoodnoughR T Coutts

❮ Previous
Next ❯

Citations

Apr 4, 2001·The International Journal of Eating Disorders·G K FrankM D Marcus
Sep 24, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Constantinos PistosJulia Atta-Politou
Oct 6, 2001·Journal of Chromatography. B, Biomedical Sciences and Applications·G TournelM Lhermitte
Jun 12, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Isis A ZainaghiRegina H C Queiroz
May 17, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·L LabatJ P Dubost
Dec 4, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Philip B Mitchell
May 3, 2003·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Göksel Altiokka, Kevser Kircali
Jul 2, 2004·Therapeutic Drug Monitoring·Finn Bengtsson
Jan 2, 2009·Journal of Pharmaceutical and Biomedical Analysis·Loretta FranceschiMario Furlanut
Nov 5, 2008·Journal of Pharmaceutical and Biomedical Analysis·M Espinosa BoschC Bosch Ojeda
Dec 2, 2010·Biomedical Chromatography : BMC·Alina Plenis, Tomasz Bączek
Dec 17, 2005·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·I KovacevicM Prostran
Feb 23, 2008·Critical Reviews in Clinical Laboratory Sciences·Sarah M R WilleWilly E E Lambert
Aug 21, 2003·European Psychiatry : the Journal of the Association of European Psychiatrists·Ann M Mortimer
Feb 16, 2021·Journal of Clinical Psychopharmacology·Domenico De DonatisLaura Mercolini
Aug 10, 2000·Journal of Pharmaceutical and Biomedical Analysis·B Starczewska, K Mielech
Aug 10, 2000·Journal of Pharmaceutical and Biomedical Analysis·B StarczewskaK Baranowska
Jun 5, 1998·Journal of Chromatography. B, Biomedical Sciences and Applications·J C AlvarezO Spreux-Varoquaux
Jan 1, 2008·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Bruno José Gonçalves SilvaMaria Eugênia Costa Queiroz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.